Dyne Therapeutics IncDYN

DYN current price
$25.73+102.60%

Capital at risk.

1W
-12.00%
1M
-21.67%
3M
-25.20%
6M
-19.06%
1Y
+102.60%
MAX
+7.66%
About Dyne Therapeutics Inc
Ticker
info
DYN
Trading on
info
NASDAQ
ISIN
info
US26818M1080
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
John G. Cox M.B.A.
Headquarters
info
1560 Trapelo Road, Waltham, MA, United States, 02451
Employees
info
173
Website
info
dyne-tx.com
Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$2.8B
P/E ratio
info
-
EPS
info
-$3.58
Dividend Yield
info
0.00%
Beta
info
1.1
Forward P/E ratio
info
0
EBIDTA
info
$-313M
Ex dividend date
info
-
Price & volume
Market cap
info
$2.8B
Average daily volume
info
0.9M
90-day return
info
-25.20%
30-day return
info
-21.67%
7-day return
info
-12.00%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0.19
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
3.96
Earnings
EPS
info
-$3.58
EPS estimate (current quarter)
info
-$0.71
EPS estimate (next quarter)
info
-$0.74
EBITDA
info
$-313M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.1
52-week High
info
$47.45
52-week Low
info
$11.66
50-day moving average
info
$30.77
200-day moving average
info
$32.74
Short ratio
info
9.33
Short %
info
12.08%
Management effectiveness
ROE (TTM)
info
68.68%
ROA (TTM)
info
40.35%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
102M
Float
info
74.8M
Insiders %
info
0.78%
Institutions %
info
112.64%
Analyst Insights & forecasts
info

90% Buy

10% Hold

0% Sell

Based on information from 10 analysts.

Average price target

info
$50.82
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$1.09
-$0.92
18.48%
Q4 • 23Beat
-$0.81
-$0.80
1.25%
Q1 • 24Beat
-$0.70
-$0.72
2.78%
Q2 • 24Beat
-$0.96
-$0.71
35.61%
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-65.1M
∞%
Q2 • 24
$0M
$-97.1M
∞%
Q3 • 24
NaN%
49.19%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$826M
$50.7M
6.14%
Q2 • 24
$769M
$63.3M
8.23%
Q3 • 24
6.91%
24.88%
34.15%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-54.9M
$11.2M
$380M
$-55.7M
Q2 • 24
$-74.6M
$-19.4M
$18M
$-74.9M
Q3 • 24
36.02%
273.64%
95.26%
34.38%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Extreme greed

+1.5

1.50

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Dyne Therapeutics Inc share?
Collapse

Dyne Therapeutics Inc shares are currently traded for $25.73 per share.

How many shares does Dyne Therapeutics Inc have?
Collapse

Dyne Therapeutics Inc currently has 102M shares.

Does Dyne Therapeutics Inc pay dividends?
Collapse

No, Dyne Therapeutics Inc doesn't pay dividends.

What is Dyne Therapeutics Inc 52 week high?
Collapse

Dyne Therapeutics Inc 52 week high is $47.45.

What is Dyne Therapeutics Inc 52 week low?
Collapse

Dyne Therapeutics Inc 52 week low is $11.66.

What is the 200-day moving average of Dyne Therapeutics Inc?
Collapse

Dyne Therapeutics Inc 200-day moving average is $32.74.

Who is Dyne Therapeutics Inc CEO?
Collapse

The CEO of Dyne Therapeutics Inc is John G. Cox M.B.A..

How many employees Dyne Therapeutics Inc has?
Collapse

Dyne Therapeutics Inc has 173 employees.

What is the market cap of Dyne Therapeutics Inc?
Collapse

The market cap of Dyne Therapeutics Inc is $2.8B.

What is the P/E of Dyne Therapeutics Inc?
Collapse

The current P/E of Dyne Therapeutics Inc is null.

What is the EPS of Dyne Therapeutics Inc?
Collapse

The EPS of Dyne Therapeutics Inc is -$3.58.

What is the PEG Ratio of Dyne Therapeutics Inc?
Collapse

The PEG Ration of Dyne Therapeutics Inc is 0.19.

What do analysts say about Dyne Therapeutics Inc?
Collapse

According to the analysts Dyne Therapeutics Inc is considered a buy.

Dyne Therapeutics Inc news